{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
... DNA (see figure JAK 2 mutation site identification). The kit provides high levels of sensitivity and reproducibility. The ipsogen JAK 2 MutaQuant Kit ...
Result display time: 75 min
Sample volume: 0.015 ml
Single-pot duplex assay with integrated reverse transcription (RT) / cDNA synthesis and qPCR. Minimal Residual Disease determination through BCR-ABL/ABL ratio reported on the International Scale (IS) when used in conjunction with the recommended GenePath ...
... This kit is used to detect the JAK 2 gene V617F mutation (COSM12600, c.1849G>T) in DNA samples extracted from tissue and cfDNA samples obtained from plasma. The JAK 2 ...
Result display time: 90 min
... Principles: This kit is a nucleic acid amplifcation test for the qualitative detection of ROS1 gene fusions in NSCLC FFPE samples. The kit is based on three major processes: (1) specimen preparation ...
Specificity: 100 %
... Janus kinase 2 ( JAK 2) is a non-receptor tyrosine kinase. The V617F mutation in the JAK 2 gene involves a valine to phenylalanine amino acid change at ...
... JAK 2 V617F mutation is found in patients with blood related disease such as Polycythemia Vera, Essential Thrombocythemia and Myelofibrosis. Ruxolitinib is effective as a JAK Inhibitor, ...
the best suppliers